Related Experiment Videos
Growth factors and muscle ageing
Geoffrey Goldspink1, Stephen D R Harridge
1Aximygen/UCL Biomedica, Division of Surgery, Royal Free and University College Medical School, The Archway Campus, 2-10 Highgate Hill, London N19 5LW, UK. goldspink@rfc.ucl.ac.uk
Experimental Gerontology
|October 27, 2004
Summary
Age-related muscle loss (sarcopenia) may be improved by growth hormone (GH) and exercise. GH treatment and resistance exercise increase mechano growth factor (MGF) production, enhancing muscle
Area of Science:
- Gerontology
- Muscle Physiology
- Endocrinology
Background:
- Sarcopenia, or age-related muscle mass loss, presents significant healthcare and socioeconomic challenges.
- The growth hormone (GH)/IGF-I axis is a key regulator of muscle mass, with both systemic and local IGF-I forms.
- Skeletal muscle expresses distinct IGF-I variants, including mechano growth factor (MGF) and IGF-IEa, with differing functions.
Purpose of the Study:
- To investigate the role of GH and exercise in modulating IGF-I splicing towards MGF in aging muscle.
- To explore the potential of MGF in ameliorating age-related sarcopenia.
Main Methods:
- Analysis of IGF-I gene expression and alternative splicing in skeletal muscle.
- Assessment of GH treatment effects on IGF-I and MGF levels in older individuals.
- Evaluation of combined GH treatment and resistance exercise interventions.
Main Results:
- IGF-I gene expression is upregulated by GH treatment in older adults.
- Combined GH treatment and resistance exercise promote increased MGF splicing.
- Age-related decline in MGF production correlates with decreased GH levels.
Conclusions:
- GH treatment and resistance exercise can enhance MGF production in aging muscle.
- Increased MGF may improve skeletal muscle's response to physical activity.
- MGF presents a potential therapeutic target for combating sarcopenia.